EE200100172A - Tetrahüdropüridoeetrid, nende kasutamine ja ravim - Google Patents

Tetrahüdropüridoeetrid, nende kasutamine ja ravim

Info

Publication number: EE200100172A
Authority: EE; Estonia
Prior art keywords: tetrahydropyridoethers; medicine; naphthyridine; imidazo; methoxyethoxy
Prior art date: 1998-09-23

Application number

EEP200100172A

Other languages

English (en)

Inventor

Senn-Bilfinger J�rg

Postius Stefan

Simon Wolfgang-Alexander

Grundler Gerhard

Hanauer Guido

Huber Reinhard

Kromer Wolfgang

Sturm Ernst

Original Assignee

Byk Gulden Lomberg Chemische Fabrik Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-23

Filing date

1999-09-17

Publication date

2002-06-17

1999-09-17 Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh

2002-06-17 Publication of EE200100172A publication Critical patent/EE200100172A/et

2006-08-15 Publication of EE04677B1 publication Critical patent/EE04677B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EEP200100172A 1998-09-23 1999-09-17 Tetrahdropridoeetrid, nende kasutamine ja ravim EE04677B1 (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19843504		1998-09-23
EP98117988		1998-09-23
PCT/EP1999/006899 WO2000017200A1 (en)	1998-09-23	1999-09-17	Tetrahydropyridoethers

Publications (2)

Publication Number	Publication Date
EE200100172A true EE200100172A (et)	2002-06-17
EE04677B1 EE04677B1 (et)	2006-08-15

Family

ID=26049024

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100172A EE04677B1 (et)	1998-09-23	1999-09-17	Tetrahdropridoeetrid, nende kasutamine ja ravim

Country Status (31)

Country	Link
US (4)	US6436953B1 (et)
EP (1)	EP1115725B1 (et)
JP (1)	JP4145492B2 (et)
KR (1)	KR100668400B1 (et)
CN (2)	CN100506821C (et)
AT (1)	ATE231862T1 (et)
AU (1)	AU763463B2 (et)
BG (1)	BG65195B1 (et)
BR (1)	BR9914044A (et)
CA (1)	CA2344251A1 (et)
CZ (1)	CZ292335B6 (et)
DE (1)	DE69905178T2 (et)
DK (1)	DK1115725T3 (et)
EA (1)	EA005377B1 (et)
EE (1)	EE04677B1 (et)
ES (1)	ES2191464T3 (et)
GE (1)	GEP20032926B (et)
HK (1)	HK1038360B (et)
HR (1)	HRP20010224A2 (et)
HU (1)	HUP0102990A3 (et)
ID (1)	ID28896A (et)
IL (2)	IL142063A0 (et)
NO (1)	NO317304B1 (et)
NZ (1)	NZ510610A (et)
PL (1)	PL193616B1 (et)
PT (1)	PT1115725E (et)
RS (1)	RS50145B (et)
SI (1)	SI1115725T1 (et)
SK (1)	SK285165B6 (et)
TR (1)	TR200100805T2 (et)
WO (1)	WO2000017200A1 (et)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6436953B1 (en) *	1998-09-23	2002-08-20	Byk Gulden Lomberg Chemische Fabrik Gmbh	Tetrahydropyridoethers
DK1173439T3 (da) *	1999-04-17	2003-09-08	Altana Pharma Ag	Halogenalkoxy-imidazonaphthyridiner
CA2721484A1 (en) *	1999-05-12	2000-11-12	President And Fellows Of Harvard College	Dopamine transporter imaging agents
JP2003528879A (ja) *	2000-03-29	2003-09-30	アルタナファルマアクチエンゲゼルシャフト	三環式イミダゾピリジン
NZ520837A (en) *	2000-03-29	2005-01-28	Altana Pharma Ag	Prodrugs of imidazopyridine derivatives
SK5072003A3 (en) *	2000-10-25	2003-09-11	Altana Pharma Ag	Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk)	2000-12-07	2007-09-25	Алтана Фарма Аг	Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
BR0207762A (pt) *	2001-03-08	2004-06-01	Astrazeneca Ab	Uso de um composto ou um sal farmaceuticamente aceitável do mesmo, combinação, formulação farmacêutica, kit, método para a prevenção da úlcera gástrica induzida por medicamento, e, composição farmacêutica oral
EP1414821B1 (en)	2001-08-02	2006-08-16	ALTANA Pharma AG	Tricyclic epoxides
EP1417208A1 (en) *	2001-08-03	2004-05-12	ALTANA Pharma AG	Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
NZ531433A (en) *	2001-08-03	2005-09-30	Altana Pharma Ag	Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
US7314935B2 (en)	2002-02-15	2008-01-01	Altana Pharma Ag	Tricyclic n-acyl compounds
MY140561A (en)	2002-02-20	2009-12-31	Nycomed Gmbh	Dosage form containing pde 4 inhibitor as active ingredient
EP1506016A2 (en) *	2002-05-07	2005-02-16	ALTANA Pharma AG	New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
PL375567A1 (en)	2002-11-19	2005-11-28	Altana Pharma Ag	8-substituted imidazopyridines
EP1572217B1 (en)	2002-12-12	2008-08-20	Nycomed GmbH	Combination medicament of r,r-formoterol and ciclesonide
RS20050449A (sr) *	2002-12-20	2007-11-15	Altana Pharma Ag.,	8-trialkisiloksi-2-metil-9-fenil-7- okso-7,8,9,10- tetrahidroimidazo /1,2h//1,7/naftiridini
RS20050603A (sr) *	2003-02-17	2007-09-21	Altana Pharma Ag.,	NOVE KOMBINACIJE I NOVA PRIMENA FARMACEUTSKIH AKTIVNIH JEDINjENjA
KR101179012B1 (ko)	2003-03-10	2012-09-03	니코메드 게엠베하	로플루미라스트 신규한 제조 방법
TW200503783A (en) *	2003-04-11	2005-02-01	Altana Pharma Ag	Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) *	2003-05-14	2008-05-04	التانا فاروا ايه جي	مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
US20060241134A1 (en) *	2003-05-27	2006-10-26	Altana Pharma Ga	Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
US20050059704A1 (en) *	2003-08-29	2005-03-17	Dynogen Pharmaceuticals, Inc.	Compositions useful for treating gastrointestinal motility disorders
ES2452691T5 (es)	2003-09-16	2022-09-14	Covis Pharma Gmbh	Uso de ciclesonida para el tratamiento de enfermedades respiratorias
EP1974730A1 (en)	2003-11-03	2008-10-01	AstraZeneca AB	Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
US7326784B2 (en)	2003-12-19	2008-02-05	Altana Pharma Ag	Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives
AR047605A1 (es) *	2004-02-17	2006-01-25	Altana Pharma Ag	Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
DK1784404T3 (da)	2004-09-03	2012-02-13	Yuhan Corp	Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
WO2006025714A1 (en)	2004-09-03	2006-03-09	Yuhan Corporation	PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
KR100958828B1 (ko)	2004-09-03	2010-05-24	주식회사유한양행	피롤로[3,2-ｂ]피리딘 유도체 및 그의 제조방법
EP1861074B1 (en) *	2005-03-16	2013-04-24	Takeda GmbH	Taste masked dosage form containing roflumilast
EP2080513A1 (en)	2008-01-16	2009-07-22	Schraermeyer, Ulrich, Prof. Dr. rer. nat	Tetrahydropyridoethers for treatment of AMD
KR101605063B1 (ko)	2009-07-09	2016-03-21	라퀄리아 파마 인코포레이티드	소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제
WO2012027240A1 (en) *	2010-08-23	2012-03-01	Schering Corporation	Fused tricyclic inhibitors of mammalian target of rapamycin
ES2635067T3 (es) *	2012-06-15	2017-10-02	Bio-Pharm Solutions Co., Ltd.	Compuesto de sulfamato de fenilalquilo y composición de relajante muscular que comprende el mismo
WO2015052256A1 (en)	2013-10-08	2015-04-16	Katairo Gmbh	Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4468400A (en) *	1982-12-20	1984-08-28	Schering Corporation	Antiulcer tricyclic imidazo [1,2-a]pyridines
CA1327796C (en)	1987-07-16	1994-03-15	Jorg Senn-Bilfinger	Diazoles
SE9401197D0 (sv) *	1994-04-11	1994-04-11	Astra Ab	Active compounds
CA2196076A1 (en) *	1994-07-28	1996-02-08	Gerhard Grundler	Acyl imidazopyridines
CZ290548B6 (cs) *	1997-03-24	2002-08-14	Byk Gulden Lomberg Chemische Fabrik Gmbh	Tetrahydropyridinové deriváty a farmaceutický prostředek
HUP0001555A3 (en) *	1997-10-30	2001-01-29	Altana Pharma Ag	Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
US6436953B1 (en)	1998-09-23	2002-08-20	Byk Gulden Lomberg Chemische Fabrik Gmbh	Tetrahydropyridoethers

1999
- 1999-09-17 US US09/582,212 patent/US6436953B1/en not_active Expired - Lifetime
- 1999-09-17 ID IDW20010682A patent/ID28896A/id unknown
- 1999-09-17 ES ES99948776T patent/ES2191464T3/es not_active Expired - Lifetime
- 1999-09-17 NZ NZ510610A patent/NZ510610A/en unknown
- 1999-09-17 CN CNB2004100384351A patent/CN100506821C/zh not_active Expired - Fee Related
- 1999-09-17 TR TR2001/00805T patent/TR200100805T2/xx unknown
- 1999-09-17 CN CNB998112992A patent/CN1155598C/zh not_active Expired - Fee Related
- 1999-09-17 PL PL99346617A patent/PL193616B1/pl not_active IP Right Cessation
- 1999-09-17 BR BR9914044-6A patent/BR9914044A/pt not_active Application Discontinuation
- 1999-09-17 EP EP99948776A patent/EP1115725B1/en not_active Expired - Lifetime
- 1999-09-17 KR KR1020017003553A patent/KR100668400B1/ko not_active Expired - Fee Related
- 1999-09-17 HU HU0102990A patent/HUP0102990A3/hu unknown
- 1999-09-17 SK SK399-2001A patent/SK285165B6/sk not_active IP Right Cessation
- 1999-09-17 CA CA002344251A patent/CA2344251A1/en not_active Abandoned
- 1999-09-17 WO PCT/EP1999/006899 patent/WO2000017200A1/en not_active Ceased
- 1999-09-17 IL IL14206399A patent/IL142063A0/xx active IP Right Grant
- 1999-09-17 HK HK02100042.6A patent/HK1038360B/en not_active IP Right Cessation
- 1999-09-17 EE EEP200100172A patent/EE04677B1/et not_active IP Right Cessation
- 1999-09-17 EA EA200100315A patent/EA005377B1/ru not_active IP Right Cessation
- 1999-09-17 PT PT99948776T patent/PT1115725E/pt unknown
- 1999-09-17 HR HR20010224A patent/HRP20010224A2/hr not_active Application Discontinuation
- 1999-09-17 DE DE69905178T patent/DE69905178T2/de not_active Expired - Lifetime
- 1999-09-17 JP JP2000574109A patent/JP4145492B2/ja not_active Expired - Lifetime
- 1999-09-17 AU AU61920/99A patent/AU763463B2/en not_active Expired
- 1999-09-17 CZ CZ20011082A patent/CZ292335B6/cs not_active IP Right Cessation
- 1999-09-17 DK DK99948776T patent/DK1115725T3/da active
- 1999-09-17 RS YUP-214/01A patent/RS50145B/sr unknown
- 1999-09-17 SI SI9930207T patent/SI1115725T1/xx unknown
- 1999-09-17 GE GEAP19995786A patent/GEP20032926B/en unknown
- 1999-09-17 AT AT99948776T patent/ATE231862T1/de not_active IP Right Cessation
2001
- 2001-02-19 BG BG105270A patent/BG65195B1/bg unknown
- 2001-03-12 NO NO20011243A patent/NO317304B1/no not_active IP Right Cessation
- 2001-03-18 IL IL142063A patent/IL142063A/en not_active IP Right Cessation
2002
- 2002-03-25 US US10/103,733 patent/US6696460B2/en not_active Expired - Lifetime
2004
- 2004-02-23 US US10/783,512 patent/US7105676B2/en not_active Expired - Lifetime
2006
- 2006-07-27 US US11/493,707 patent/US7393860B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7105676B2 (en)	2006-09-12
EP1115725A1 (en)	2001-07-18
NO20011243D0 (no)	2001-03-12
TR200100805T2 (tr)	2001-08-21
PL193616B1 (pl)	2007-02-28
DK1115725T3 (da)	2003-06-23
ID28896A (id)	2001-07-12
NO317304B1 (no)	2004-10-04
CN1155598C (zh)	2004-06-30
IL142063A (en)	2007-10-31
AU6192099A (en)	2000-04-10
EE04677B1 (et)	2006-08-15
CZ20011082A3 (cs)	2001-09-12
DE69905178D1 (de)	2003-03-06
NO20011243L (no)	2001-03-12
KR100668400B1 (ko)	2007-01-17
US6436953B1 (en)	2002-08-20
ATE231862T1 (de)	2003-02-15
CN1319101A (zh)	2001-10-24
DE69905178T2 (de)	2003-07-17
US6696460B2 (en)	2004-02-24
GEP20032926B (en)	2003-03-25
KR20010075223A (ko)	2001-08-09
PL346617A1 (en)	2002-02-25
CN1560055A (zh)	2005-01-05
RS50145B (sr)	2009-03-25
WO2000017200A1 (en)	2000-03-30
BG65195B1 (bg)	2007-06-29
IL142063A0 (en)	2002-03-10
JP2002526499A (ja)	2002-08-20
AU763463B2 (en)	2003-07-24
PT1115725E (pt)	2003-06-30
BR9914044A (pt)	2001-12-04
JP4145492B2 (ja)	2008-09-03
SI1115725T1 (en)	2003-06-30
SK3992001A3 (en)	2001-12-03
BG105270A (en)	2001-11-30
EA200100315A1 (ru)	2001-10-22
US7393860B1 (en)	2008-07-01
ES2191464T3 (es)	2003-09-01
CN100506821C (zh)	2009-07-01
NZ510610A (en)	2003-07-25
EP1115725B1 (en)	2003-01-29
EA005377B1 (ru)	2005-02-24
HK1038360B (en)	2003-05-16
HUP0102990A2 (hu)	2002-01-28
US20020169320A1 (en)	2002-11-14
CZ292335B6 (cs)	2003-09-17
HUP0102990A3 (en)	2002-09-30
CA2344251A1 (en)	2000-03-30
YU21401A (sh)	2004-03-12
US20040162310A1 (en)	2004-08-19
SK285165B6 (sk)	2006-07-07
HK1038360A1 (en)	2002-03-15
HRP20010224A2 (en)	2002-04-30

Publication	Publication Date	Title
EE200100172A (et)	2002-06-17	Tetrahüdropüridoeetrid, nende kasutamine ja ravim
EE04676B1 (et)	2006-08-15	Imidasopridiini derivaadid, mis inhibeerivad maohappesekretsiooni, protsess nende valmistamiseks ning nende kasutamine
EE04800B1 (et)	2007-04-16	Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
FI971529L (fi)	1997-04-11	Uudet karboksyylihappojohdannaiset, niiden valmistus ja käyttö
NO961006L (no)	1996-09-16	Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
EE04578B1 (et)	2006-02-15	Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nendesolvaatide suu kaudu manustamiseks
FI963298L (fi)	1996-10-23	Hydrokseemihappo- ja karboksyylihappojohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö
NO911934L (no)	1991-11-20	Fremgangsmaate for fremstilling av bicykliske 1-aza-cykloalkaner.
NO986056D0 (no)	1998-12-22	Faste orale doseringsformer av valsartan
FI974440A0 (fi)	1997-12-05	Bifenyyli-2-karboksyylihappo-tetrahydro-isokinolin-6-yyli-amidijohdannaisia, niiden valmistus ja niiden käyttö mikrosomaalistatriglyseridiä siirtävän proteiinin ja/tai apolipoproteiini B:n (Apo B) erittymiseen inhibiittoreina
EE03568B1 (et)	2001-12-17	Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
NO895160L (no)	1990-06-21	Mikrobiell fremgangsmaate for fremstilling av immunhemmende antibiotika.
EE9800302A (et)	1999-02-15	Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
EE03682B1 (et)	2002-04-15	Asendatud bensimidasooli derivaadid, protsessid nende valmistamiseks ning nende kasutamine
FI956298L (fi)	1996-06-30	3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
NO980008D0 (no)	1998-01-02	Fremgangsmåte for fremstilling av slanger for medisinsk bruk
ZA200201521B (en)	2003-05-22	Alkoxy substituted benzimidazole compounds, pharmaceutical preparation containing the same, and methods of using the same.
IS2199B (is)	2007-02-15	Svæfandi ß-karbólín afleiður, aðferð til framleiðslu þeirra og notkun þeirra sem læknislyf
NO20003454L (no)	2000-07-04	FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
EE200000537A (et)	2001-06-15	Pürasolo[4,3-d]pürimidiin-7-oon-3-püridüülsulfonüülühendite ja nende vaheühendite valmistamise protsess
DE59708511D1 (de)	2002-11-21	Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
NO984189D0 (no)	1998-09-11	Fremgangsmåte for behandling av bipolar forstyrrelse
NO961429D0 (no)	1996-04-11	Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
FI982191A0 (fi)	1998-10-08	Menetelmä putkiliitoksen tekemiseksi, putkiliitos ja pistopää
EP1595879A3 (en)	2010-01-27	Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Legal Events

Date	Code	Title	Description
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2011-06-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20100917